EDIT vs EW
Editas Medicine Inc (EDIT) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
EDIT currently screens at market cap $375.2M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the EDIT and EW stock pages for the full models.
Not investment advice.